Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Oscillococcinum in the treatment of influenza-like illness symptoms
2020-002972-11Phase 4Completed
- Sponsor
- Boiron
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of Oscillococcinum in influenza-like illness (ILI) (2 arms), sponsored by Boiron. Started Sep 2020; status: completed.
02
Drugs
Oscillococcinum
03
Conditions
influenza-like illness (ILI)
Beyond the preview
Go deeper on 2020-002972-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002972-11.